Browse the full directors' dealings record of Spyre Therapeutics, Inc., a listed equity based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €6.6bn. The latest transaction was filed on 3 June 2026 (Levée d'options). Among the most active insiders: Burrows Scott L. Every trade is accessible without an account.
14
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€694,219
5 ops.
Sell Volume
30Σ signal
Buys ·€694,219 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.